Jinling Pharmaceutical Company Limited (SHE:000919)
China · Delayed Price · Currency is CNY 7.78
+0.16 (2.10%)
Feb 4, 2026, 2:45 PM CST
SHE:000919 Revenue
Jinling Pharmaceutical Company had revenue of 779.07M CNY in the quarter ending September 30, 2025, a decrease of -4.53%. This brings the company's revenue in the last twelve months to 3.13B, down -13.52% year-over-year. In the year 2024, Jinling Pharmaceutical Company had annual revenue of 3.28B with 2.74% growth.
Revenue (ttm)
3.13B
Revenue Growth
-13.52%
P/S Ratio
1.51
Revenue / Employee
540.85K
Employees
5,789
Market Cap
4.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.28B | 87.45M | 2.74% |
| Dec 31, 2023 | 3.19B | 523.03M | 19.58% |
| Jan 1, 2023 | 2.67B | -137.79M | -4.91% |
| Jan 1, 2022 | 2.81B | 305.02M | 12.18% |
| Dec 31, 2020 | 2.50B | -31.19M | -1.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Ningbo Menovo Pharmaceutical | 1.54B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.17B |
| Shanghai Xiao Fang Pharmaceutical | 504.59M |